A team of 15 lawyers across four different Norton Rose Fulbright offices in the US have decamped to join Reed Smith. The team includes global head of life sciences and healthcare Rick Robinson, Washington partner Lesley Reynolds, Austin partners Jeff Layne and Ben Koplin and New York partner Cori Goldberg. Two Norton Rose associates, Washington […]
Linklaters is acting for Takeda Pharmaceuticals in the ongoing tussle for Irish drug maker Shire, represented by Slaughter and May.
Freshfields Bruckhaus Deringer is advising Advent International on its potential €2bn deal with French pharmaceuticals company Sanofi.
McDermott Will & Emery has hired a life sciences team in Frankfurt from Dechert, which just yesterday saw a team decamp from its London office for Goodwin Procter. The team is being led by partner Rüdiger Herrmann, who joined Dechert in 2014 from WilmerHale. He was also a partner at Mayer Brown between 2001 and […]
As a former chemistry student, Hogan Lovells IP partner Daniel Brook has honed his legal and science knowledge to become indispensable to several of the world’s largest pharmaceutical companies looking to safeguard their products. One of the most important judgments last year was Eli Lilly’s landmark patent trial against pharmaceutical rival Actavis. Brook took the […]
Sage’s GC shares how she helps her in-housers develop their leadership skills and what she looks for when hiring talent.
As part of the ongoing dispute that sees Addleshaw Goddard caught up in the insolvency of a string of family-owned caravan parks, Pinsent Masons has been called on to defend big four accountancy firm Deloitte from a professional negligence claim for advice it gave during that same insolvency. In May, The Lawyer reported that City-based Pinsents partners […]
BT group general counsel Sabine Chalmers has written to lawyers at the telecomms business in a bid to curb fears over job losses which have now spread to its legal team. BT CEO Gavin Patterson has been the most high-profile casualty of the business’s recent struggles as he was asked to step down by shareholders […]
There are three things that keep City managing partners awake at night. First, the US firms. Second, tech and New Law. And third, Brexit. This week saw all three issues in the spotlight. The extent of US firms’ growth in London was shown by the unveiled City 50, The Lawyer’s ranking of US and UK […]
CVC Capital Partners has acquired a majority stake in alternative legal services provider UnitedLex in what is believed to be the largest investment in the legal market ever at $500m. UnitedLex CEO Dan Reed led negotiations in-house. The Lawyer can reveal that CVC was advised by a White & Case team led by New York-based partner […]
Orrick, Latham & Watkins and Fenwick & West have taken the lead advising on luxury online retailer FarFetch‘s IPO on the New York Stock Exchange. Latham & Watkins is advising FarFetch, with a capital markets team led by New York partners Marc Jaffe and Ian Schuman, and London partner Joshua Kiernan. Orrick is acting for a […]
GSK’s assistant general counsel talks to The Lawyer about the steps she takes to avoid disappointment in the mentor-mentee relationship.
Former Allen & Overy (A&O) head of intellectual property Nicola Dagg was leading on 75 per cent of the firm’s cases in the sector before the announcement of her high-profile move to US firm Kirkland & Ellis earlier this year, data from The Lawyer can reveal. Data gathered for The Lawyer Litigation Tracker Q2 shows that of the firm’s four […]
Flexible lawyering service Lawyers On Demand (LOD) has laid out its plans for significant growth in the US with hopes that it will become the provider’s biggest market in the next “few years”. In a bid to further its ambitions in the US, LOD co-founder John Knox relocated to the North Eastern state of Connecticut […]
By Luca van Silfhout, Patrick Vettenburg A number of goods and services, listed in an annex to the Dutch VAT Act, qualify for the reduced VAT rate (instead of the regular VAT rate of currently 21%). Among these goods and services are: qualifying medicines, first-aid type supplies such as bandages and qualifying medical aids such […]
By Ajay Bhargava, Arvind Kumar Ray, Karan Gupta In the recent case of Modi-Mundipharma Private Limited v Union of India & Ors., (Writ Petition (Civil) No. 11802 of 2016), the High Court of Delhi (Court) has clarified that incremental innovation or novel drug delivery systems like lipid / liposomal formulations, sustained release, controlled release, etc. should […]
By Alexander Camenzind On September 21, 2017, the Certificate of Supplementary Protection Regulations (“CSP Regulations”) came into force, providing for the first time the ability to obtain an extended period of patent protection for human and veterinary drugs in Canada. With the first anniversary of the program quickly approaching, an overview of its implementation may prove […]
By Martin Schoonewille, Frank Leijdesdorff, Leon Engelen The hospital Bernhoven in Uden and Oss gives employees the opportunity to buy bonds and thereby indirectly become ‘co-owners’ of the hospital. From 2019 local residents can also obtain bonds. The hospital hopes to increase the involvement of staff and patients, according to the press release. The hospital has a bank loan […]
By Paulo Pinheiro, Francisca Paulouro, Pedro Fontes VdA contributes to the 1st edition of “Global Legal Insights: Pricing & Reimbursement” published by Global Legal Group. Some of the firm’s members have written the chapters for Portugal, Angola and Mozambique, which focus on, amongst others, the legislation regarding pricing and reimbursement of medicinal products in those countries.
By Paulo Pinheiro, Francisca Paulouro, Pedro Fontes VdA contributes to the 1st edition of “Global Legal Insights: Pricing & Reimbursement” published by Global Legal Group. Some of the firm’s members have written the chapters for Portugal, Angola and Mozambique, which focus on, amongst others, the legislation regarding pricing and reimbursement of medicinal products in those countries.
By: Andreas Natterer, Michaela Pohl, Thomas Kulnigg The traditional Austrian bakery Aida, which is known for its staff dressed in baby pink, will sell brownies containing CBD. The price will be EUR 4.20 – an inside joke, since “four-twenty” is code for the consumption of cannabis. The fact that an old-school, stuffy bakery like Aida is […]
By Dieuwertje van Dijk Minister Bruins (Medical Care and Sport) of the Ministry of Health, Welfare and Sport ( VWS ) condemns the behavior of pharmaceutical Leadiant to the strong price increase of the drug CDCA. He wrote this in a letter to the House of Representatives last Monday . CDCA (chenodeoxycholic acid) is used as a medicine in the treatment […]
Mental health is an issue that is becoming increasingly prevalent in both our home and working lives. According to statistics published by the Mental Health Foundation, nearly half (43.4%) of UK adults believe they have had a diagnosable mental health condition at some point in their life. According to a CIPD/Simplyhealth Health and Well-being at […]
Dutch Minister of Medical Care initiates dialogue with the ACM concerning potential abuse of dominance by pharmaceutical companies. In a letter of 16 November 2017, the Minister addresses the complexity of the development of medicines and the problem that expensive medicines pose to the national health care budget. The Minister also announced that he will […]
On 30 November 2017 the Dutch Healthcare Authority issued a fine of € 70.000 to a healthcare provider that failed to notify a concentration. The healthcare provider had acquired certain personnel from other healthcare providers and this transaction exceeded the 50 person threshold for notification to the Dutch Healthcare Authority. The Dutch Healthcare Authority qualified the […]
Most people involved in the life sciences or healthcare sector are aware, or at least have heard of, the “Sunshine Act”. The “Sunshine Act”, now a familiar concept in the EU, is the abbreviated title of the 2010 US Physician Payments Sunshine Act, which was adopted as part of the Affordable Care Act (better known […]
